Refining the Role of ERK Signaling in Anthracycline-Induced Cardiotoxicity [0.03%]
ERK信号在蒽环类药物诱导的心脏毒性中的作用研究
Zheyu Wang,Defeng Zhao
Zheyu Wang
REPLY: Next Steps for Studying Behaviorally Designed Gamification to Increase Physical Activity [0.03%]
行为导向的游戏化促进身体活动的增加：下一步的研究步骤
Alexander C Fanaroff,Bonnie Ky,Kevin G Volpp et al.
Alexander C Fanaroff et al.
Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity [0.03%]
乳腺癌化疗期间血浆IL-18水平、运动能力和身体活动的关系
Moriah P Bellissimo,Matthew Ambrosio,Adolfo Gabriele Mauro et al.
Moriah P Bellissimo et al.
Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy [0.03%]
双特异性T细胞重定向抗体治疗后的心血管不良事件
Eli Grunblatt,Sawsan A Alkhalili,Zhiying Meng et al.
Eli Grunblatt et al.
Adrian C Chen,Javid J Moslehi
Adrian C Chen
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor-Associated Myocarditis [0.03%]
程序性死亡配体1（PD-L1）在免疫检查点抑制剂相关心肌炎中心肌的表达作为不良预后的标志物
Takuro Imaoka,Shingo Sakashita,Satoshi Matsuoka et al.
Takuro Imaoka et al.
Background: Immune checkpoint inhibitors (ICIs) have improved cancer outcomes but are associated with severe immune-related adverse events, including myocarditis. PD-L1 plays an important role in immune regulation and hom...
Cardiovascular Safety of T Cell Engagers: Reassuring Overall, But Not Benign for All [0.03%]
T细胞结合剂的心血管安全性：总体令人放心，但并非对所有人都无害
Qun Shao,Tong Liu,Yue Li et al.
Qun Shao et al.
Cardiac Biomarker Complete Response in Light Chain Amyloidosis: How Much of the Heart Is Captured? [0.03%]
轻链淀粉样变性中心脏生物标志物完全缓解的评估：如何量化心脏受累程度？
Alexander H Gunn,Cristiana Costa Chase,Michel G Khouri
Alexander H Gunn